Compare GCTS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GCTS | ZTEK |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.1M | 89.3M |
| IPO Year | N/A | N/A |
| Metric | GCTS | ZTEK |
|---|---|---|
| Price | $1.45 | $0.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 144.9K | 41.2K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,893,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,205.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $0.90 | $0.62 |
| 52 Week High | $2.81 | $1.84 |
| Indicator | GCTS | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 41.38 |
| Support Level | $1.37 | $0.70 |
| Resistance Level | $1.48 | $0.79 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 83.42 | 15.62 |
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.